Related Experiment Video
Updated: Dec 9, 2025

07:43
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Published on: February 8, 2017
27.8K
Targeting the Tumor Microenvironment in Brain Metastasis.
Nisha Giridharan1, Isabella C Glitza Oliva2, Barbara J O'Brien3
1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 422, Houston, TX 77030, USA.
Neurosurgery Clinics of North America
|September 14, 2020
Summary
The brain tumor microenvironment (TME) is crucial for cancer cells to colonize the brain. Understanding the TME offers new therapeutic targets for treating brain metastasis.
Area of Science:
- Oncology
- Neuroscience
- Cancer Biology
Background:
- Metastasis involves complex interactions between cancer cells and their microenvironment.
- Brain metastasis requires tumor cells to adapt to the central nervous system (CNS) and evade immune responses.
- The brain tumor microenvironment (TME) significantly influences the metastatic cascade.
Purpose of the Study:
- To review the role of the TME in the development and progression of brain metastasis.
- To highlight potential TME-directed targeted therapies for brain metastasis.
Main Methods:
- Literature review synthesizing current research on the TME and brain metastasis.
- Analysis of studies investigating cellular and molecular components of the brain TME.
- Identification of therapeutic strategies targeting the TME.
Main Results:
- The TME provides essential support for tumor cell survival, immune evasion, and growth within the brain.
- Specific components of the brain TME, such as immune cells and extracellular matrix, facilitate metastatic colonization.
- Targeting TME interactions presents a promising avenue for novel therapeutic interventions.
Conclusions:
- The TME is a critical determinant of successful brain metastasis.
- Modulating the TME holds significant therapeutic potential for improving outcomes in patients with brain metastasis.
- Further research into TME-brain interactions can guide the development of effective targeted therapies.
Related Concept Videos
The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K

